This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eli Lilly and Company. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Emmanuel Onobun: Innovator in cGAS Inhibitors
Introduction
Emmanuel Onobun is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of cGAS inhibitors. His work focuses on innovative compounds that have the potential to treat various immune-mediated diseases.
Latest Patents
Emmanuel Onobun holds a patent for novel cGAS inhibitor compounds. This invention relates to pharmaceutical compositions comprising these compounds and methods for using them to address certain pathological conditions. The patent highlights the importance of these inhibitors in the treatment of immune-mediated diseases.
Career Highlights
Emmanuel Onobun is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role involves research and development, where he applies his expertise to advance therapeutic solutions. His dedication to innovation has positioned him as a key player in his field.
Collaborations
Emmanuel has collaborated with talented individuals such as Francisco Javier Agejas Chicharro and Adel Ahmed. These partnerships enhance the research environment and contribute to the advancement of their collective work.
Conclusion
Emmanuel Onobun's contributions to the field of cGAS inhibitors exemplify the impact of innovative research in medicine. His work at Eli Lilly and Company and his patent for novel compounds underscore his commitment to improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile